Neuralink develops ultra-high bandwidth brain-machine interfaces to connect humans and computers, with the goal of treating neurological disorders and enhancing human cognition.
Track Neuralink IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Neuralink is valued at $9.7B as of the most recent funding round.
Neuralink is currently classified as pre-IPO. No S-1 has been publicly filed. Monitor TechStackIPO for the latest IPO status updates.
Neuralink is a Healthcare Technology company. Neuralink develops ultra-high bandwidth brain-machine interfaces to connect humans and computers, wi.
Neuralink scores 53/100 on TechStackIPO's IPO readiness index, which evaluates funding stage, valuation trajectory, S-1 filing status, and market timing signals.